Related Experiment Video
Updated: Apr 8, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
[Disulfiram in outpatient treatment of alcohol dependency]
1Bezirkskrankenhaus Kempten, Akademisches Lehrkrankenhaus, Universität Ulm, Robert-Weixler-Str. 46, 87439, Kempten, Deutschland.
Aim:
The alcohol deterrent drug disulfiram plays a minor role in the treatment of alcohol dependency in Germany. The study looks at the efficacy, tolerability and feasibility of a disulfiram outpatient treatment program in a German psychiatric hospital.
Method:
Data from 190 outpatients with alcohol dependency, who had participated in a disulfiram therapy program at the psychiatric outpatient department over a period of 10 years, were analyzed with respect to efficacy and tolerability. To test for predictors, independent variables and treatment success as a dependent variable a logistic regression was carried out.
Results:
After 1 year 24.2 % of the patients maintained alcohol abstinence while 55 % had had an alcohol relapse despite being in the disulfiram program. No severe complications were observed under disulfiram treatment. Therapy success was largely related to participating in treatment-specific group therapy.
Conclusion:
Disulfiram proved to be a well-tolerated medication as part of multimodal therapy of alcohol dependency. The disulfiram program was easily integrated into other health service treatment. Approximately one quarter of patients who had had an unfavorable course before, achieved abstinence, while participation in group therapy was a major predictor of treatment success. Disulfiram is a medication, which in the context of a psychosocial treatment concept, should receive a wider distribution in Germany.
More Related Videos
08:05A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
Published on: January 5, 2018
07:31Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
Published on: January 7, 2019
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Drug Metabolism: Phase II Reactions
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Drug Therapy
Antianxiety Medications
Conversion of Alcohols to Alkyl Halides